Aphria (TSX:APHA; NYSE:APHA) has launched CannRelief, a cannabidiol (CBD)-based nutraceutical and cosmetics line, through its subsidiary Aphria Deutschland.
Featuring hemp-derived CBD, CannRelief products are produced in the EU and will be distributed by CC Pharma, another Aphria subsidiary that has access to some 13,000 pharmacies across Germany.
CannRelief’s CBD oils are already available in 5% and 10% concentrations in select stores throughout Germany. The full range of CannRelief products will be introduced in 2019 via a phased rollout.
